Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

Antiepileptic drug use is not significantly associated with dementia risk in patients in Germany

Antiepileptic Drugs Not Tied to Dementia Risk

No increased overall risk found, but levetiracetam generic brands tied to higher dementia risk
For statin-treated patients with elevated triglycerides and established cardiovascular disease or diabetes

ACC: Icosapent Ethyl Beneficial for Statin-Treated Patients

Risk for ischemic events lower for patients with elevated triglycerides and atherosclerosis or diabetes
Oral forms of medications contain an average of 8.8 inactive ingredients

Average of 8.8 Inactive Ingredients Found in Oral Medications

Overall, 92.8 percent of oral solid medications contain at least one potential allergen
The number of children younger than age 6 years treated at U.S. emergency departments for medicine poisonings has declined in recent years

Young Child Goes to ED for Medicine Poisoning Every 10 Minutes

Safe medicine storage in the home needs to begin well before infants are on the move
Polypharmacy and complex medication regimens are common in patients with interstitial lung disease

Complex Dosing, Polypharmacy Common With Interstitial Lung Disease

Patients receiving systemic corticosteroids are at high risk for drug-disease interactions
For HIV-infected patients

One-Month Regimen Noninferior for Preventing HIV-Related TB

One-month rifapentine, isoniazid noninferior to nine months of isoniazid alone
Bempedoic acid

Adding Bempedoic Acid to Statin Therapy Reduces LDL Cholesterol

Genetic variants mimicking effect of ATP citrate lyase inhibitors, statins lower LDL-C in same way
A short regimen is noninferior to a long regimen for patients with rifampin-resistant tuberculosis that is susceptible to fluoroquinolones and aminoglycosides

Short Regimen Noninferior for Rifampin-Resistant Tuberculosis

Short regimen of nine to 11 months noninferior to 20-month regimen following WHO guidelines
Monthly long-acting cabotegravir and rilpivirine are noninferior to daily regimens for patients with HIV-1

Long-Acting Regimen Noninferior to Daily ART for HIV-1

Monthly long-acting cabotegravir and rilpivirine noninferior in two randomized controlled trials
Treatment with dasotraline (4 mg/day) significantly improves attention-deficit/hyperactivity disorder symptoms in children aged 6 to 12 years

Dasotraline Promising for the Treatment of ADHD in Children

Once-daily dosing tolerable, may lessen side effects